Yang L - Search Results

1

First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis.

Yang L, Song X, Zeng W, Zheng Z, Lin W. Yang L, et al. Orphanet J Rare Dis. 2023 Oct 16;18(1):326. doi: 10.1186/s13023-023-02925-w. Orphanet J Rare Dis. 2023. PMID: 37845696 Free PMC article.

2

Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma.

Yang L, Cao X, Li N, Zheng B, Liu M, Cai H. Yang L, et al. Ther Adv Med Oncol. 2022 Aug 3;14:17588359221116604. doi: 10.1177/17588359221116604. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35958872 Free PMC article.

3

Cost-effectiveness analysis of lenvatinib plus pembrolizumab compared with chemotherapy for patients with previously treated mismatch repair proficient advanced endometrial cancer in China.

Zheng Z, Yang L, Xu S, Zhu H, Cai H. Zheng Z, et al. Among authors: yang l. Front Pharmacol. 2022 Sep 30;13:944931. doi: 10.3389/fphar.2022.944931. eCollection 2022. Front Pharmacol. 2022. PMID: 36249813 Free PMC article.

4

Efficacy and safety of rituximab biosimilars or reference product as first-line treatment in patients with low-tumour-burden follicular lymphoma: A systematic review and meta-analysis.

Yang L, Zheng Z, Li N, Zheng B, Liu M, Cai H. Yang L, et al. J Clin Pharm Ther. 2022 Dec;47(12):1923-1931. doi: 10.1111/jcpt.13799. Epub 2022 Nov 7. J Clin Pharm Ther. 2022. PMID: 36345167 Review.

5

The Efficacy of Laughter Therapy on Psychological Symptoms in People With Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.

Lin G, Yang L, Wang Y, Lin R, Huang B, Sheng X, Wu X, Cao Z. Lin G, et al. Among authors: yang l. Psychooncology. 2024 Nov;33(11):e70010. doi: 10.1002/pon.70010. Psychooncology. 2024. PMID: 39472305

6

Efficacy and safety of adding bevacizumab biosimilar or original drug to platinum-based chemotherapy as first-line treatment in patients with advanced NSCLC: a systematic review and meta-analysis.

Yang L, Liu M, Cao X, Li N, Zheng B, Deng J, Cai H. Yang L, et al. Ther Adv Med Oncol. 2022 Oct 20;14:17588359221130501. doi: 10.1177/17588359221130501. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36312816 Free PMC article.

7

Aloe vera for prevention and treatment of infusion phlebitis.

Zheng GH, Yang L, Chen HY, Chu JF, Mei L. Zheng GH, et al. Among authors: yang l. Cochrane Database Syst Rev. 2014 Jun 4;2014(6):CD009162. doi: 10.1002/14651858.CD009162.pub2. Cochrane Database Syst Rev. 2014. PMID: 24895299 Free PMC article. Review.

8

Ferroptosis boosted oral cancer photodynamic therapy by carrier-free Sorafenib-Ce6 self-assembly nanoparticles.

Xu Y, Yang L, Wang C, Sun W, Zheng Y, Ou B, Wu L, Shi L, Lin X, Chen W. Xu Y, et al. Among authors: yang l. J Control Release. 2024 Feb;366:798-811. doi: 10.1016/j.jconrel.2023.12.056. Epub 2024 Jan 25. J Control Release. 2024. PMID: 38184236

9

A meta-analysis of the utility of transabdominal ultrasound for evaluation of gastric cancer.

Zhang Y, Zhang J, Yang L, Huang S. Zhang Y, et al. Among authors: yang l. Medicine (Baltimore). 2021 Aug 13;100(32):e26928. doi: 10.1097/MD.0000000000026928. Medicine (Baltimore). 2021. PMID: 34397938 Free PMC article. Review.

10

Transgenerational inheritance of promoter methylation changes in extrauterine growth restriction-induced pulmonary arterial pressure disorders.

Tang L, Chen P, Yang L, Liu J, Zheng Y, Lin J, Chen S, Luo Y, Chen Y, Ma X, Zhang L. Tang L, et al. Among authors: yang l. Ann Transl Med. 2021 Oct;9(20):1551. doi: 10.21037/atm-21-4715. Ann Transl Med. 2021. PMID: 34790757 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,442 results

Search Page

Filters